Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Other Non Operating Income (2017 - 2025)

Historic Other Non Operating Income for Ironwood Pharmaceuticals (IRWD) over the last 5 years, with Q3 2025 value amounting to $40000.0.

  • Ironwood Pharmaceuticals' Other Non Operating Income changed N/A to $40000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $414000.0, marking a year-over-year change of. This contributed to the annual value of $788000.0 for FY2024, which is 1193.18% up from last year.
  • Per Ironwood Pharmaceuticals' latest filing, its Other Non Operating Income stood at $40000.0 for Q3 2025.
  • In the past 5 years, Ironwood Pharmaceuticals' Other Non Operating Income registered a high of $40000.0 during Q3 2025, and its lowest value of $37000.0 during Q1 2025.